234 related articles for article (PubMed ID: 25889416)
21. Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma.
Yuan J; Liu S; Yu Q; Lin Y; Bi Y; Wang Y; An R
Acta Histochem; 2013 Jun; 115(5):470-4. PubMed ID: 23245688
[TBL] [Abstract][Full Text] [Related]
22. Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer.
Rolland P; Deen S; Scott I; Durrant L; Spendlove I
Clin Cancer Res; 2007 Jun; 13(12):3591-6. PubMed ID: 17575223
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of HLA class I heavy chain expression in patients with gastric cancer.
Ueda Y; Ishikawa K; Shiraishi N; Yokoyama S; Kitano S
J Surg Oncol; 2008 Apr; 97(5):451-5. PubMed ID: 18247377
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
25. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P; Lee CC; Chen LF
Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic analysis of curative surgery for stage IIIA-N2 non-small cell lung cancer].
Liu JW; Li J; Lin G; Shang XQ
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):50-3. PubMed ID: 23648301
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer.
Lim SB; Yu CS; Jang SJ; Kim TW; Kim JH; Kim JC
Dis Colon Rectum; 2010 Apr; 53(4):377-84. PubMed ID: 20305435
[TBL] [Abstract][Full Text] [Related]
29. Distinctive oncological features of stage IIIA colorectal cancer: Analysis of prognostic factors for selective adjuvant chemotherapy.
Park SY; Choi GS; Park JS; Kim HJ; Sakai Y; Hasegawa S; Watanabe T; Kim SH
J Surg Oncol; 2015 Jun; 111(7):882-90. PubMed ID: 25847023
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB
Oncology; 2013; 85(5):283-9. PubMed ID: 24217184
[TBL] [Abstract][Full Text] [Related]
31. The expression of vascular endothelial growth factor determines the efficacy of post-operative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Ogata Y; Matono K; Mizobe T; Ishibashi N; Mori S; Akagi Y; Ikeda S; Ozasa H; Murakami H; Shirouzu K
Oncol Rep; 2006 May; 15(5):1111-6. PubMed ID: 16596171
[TBL] [Abstract][Full Text] [Related]
32. [Relationship between PUMA and BIM expression in colorectal cancer and tumor invasion, metastasis and prognosis].
Yuan H; Tu SL; He XJ
Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):547-51. PubMed ID: 24091272
[TBL] [Abstract][Full Text] [Related]
33. [Effect of Chinese materia medica combined chemotherapy on the survivals of stage II and III colorectal cancer].
Lu XM; Zheng J; Zhu YJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Sep; 32(9):1166-70. PubMed ID: 23185751
[TBL] [Abstract][Full Text] [Related]
34. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in the patients with T2N0M0 colorectal cancer.
Xu B; Yu L; Zhao LZ; Ma DW
World J Surg Oncol; 2016 Mar; 14():76. PubMed ID: 26965721
[TBL] [Abstract][Full Text] [Related]
36. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
37. Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients.
Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
Ann Surg Oncol; 2013 Sep; 20(9):2914-20. PubMed ID: 23760586
[TBL] [Abstract][Full Text] [Related]
38. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
[TBL] [Abstract][Full Text] [Related]
39. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
40. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
